Tag: NSCLC
Drug-adapted RET mutations
RET is a protein tyrosine kinase that is upregulated and activated in many diverse forms of cancer. Treatments using RET-specific inhibitors have been highly effective, but the threat of resistance to these drugs looms. For this reason, Dr Jie Wu and Dr Blaine Mooers from the University of Oklahoma, together with Dr Vivek Subbiah from the University of Texas, decided […]
Exploring a novel approach to lung cancer treatment
Lung cancer, just like other types of cancer, is mostly treatable when diagnosed in the earliest stages. Treatments mainly include chemotherapy and surgeries such as sublobar resection and lobectomy. The thoracic surgical team led by Dr Calvin Ng at Prince of Wales Hospital, The Chinese University of Hong Kong, have successfully applied a novel approach to lung cancer treatment. They […]
Read More… from Exploring a novel approach to lung cancer treatment
Novel imaging technique could lead to early diagnosis of lung cancer
Non-small cell lung cancer is one of the most widespread forms of the disease. As with many other cancers, the best chance of survival comes with early diagnosis; unfortunately, at present this often doesn’t happen. In research that has the potential to improve the prognosis of lung cancer patients, Dr Claudio Scafoglio and colleagues at the University of California, Los […]
Read More… from Novel imaging technique could lead to early diagnosis of lung cancer